Drug intelligence / Profile preview

mHsp70-targeted peptide

Development stage
Preclinical
Lead developer
Technical University of Munich
Modality
Peptides
Administration
Intravenous, Topical
01

Overview

The mHsp70-targeted peptide is a specialized peptide sequence designed to selectively bind to the membrane-bound form of the 70 kDa heat shock protein (mHsp70). While Hsp70 is typically a cytoplasmic chaperone, it is frequently overexpressed on the plasma membrane of malignant cells, particularly in aggressive brain tumors like glioblastoma, where it contributes to high migratory and invasive activity. This peptide is engineered to cross the blood-brain barrier and accumulate within tumor tissues. It has been investigated for two primary applications: as a fluorescently labeled probe for intraoperative imaging to help surgeons delineate tumor margins in real-time, and as a potential targeted delivery vehicle for carrying therapeutic payloads directly to cancer cells. Preclinical studies in rodent glioma models (GL261 and C6) have demonstrated its high targeting efficiency and retention within the tumor microenvironment following intravenous administration.

Other names
mHsp70-binding peptidemHsp-70-binding peptidemHsp 70-binding peptidemembrane-bound Hsp70-targeted peptideHsp70-targeting peptideHsp-70-targeting peptideHsp 70-targeting peptide
02

Targets

HSPA1A (HSP70-1A)

Beyond the preview

Go deeper on mHsp70-targeted peptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mHsp70-targeted peptide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call